PMA_age_indications

Documents (2,236) JSON TSV

source DB	source ID	text	size	updated at	# proj.	updated_at
DevicePMAs@therightstef	P030025_S017	Approval to change the in-process coating weight acceptance criteria. The device, as modified, will be marketed under the trade name taxus express2 paclitaxel-eluting coronary stent system and is ind	351 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P100023_S000	Approval for the ion paclitaxel-eluting coronary stent system. This device is indicated for improving luminal diameter for the treatment of de nove lesions in native coronary arteries >=2.25 mm to <=	247 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P060008_S000	Approval for the taxus libert paclitaxel-eluting coronary stent system. The device is indicated for improving luminal diameter for the treatment of de novo lesions <= 28 mm in length in native corona	247 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P070015_S128	Approval for the xience v and xience nano everolimus eluting coronary stent system, xience prime and xience prime ll everolimus eluting coronary stent system, xience xpedition, xience xpedition sv and	1.89 KB	2020-03-03	11	-
DevicePMAs@therightstef	P030025_S021	Approval for stent diameters which expand the product matrix to include 2.25 mm and 4.0mm taxus express2 paclitaxel-eluting coronary stent systems. the device, asmodified, will be marketed under the t	560 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P160043_S000	Approval for the Resolute Onyx Zotarolimus-Eluting Coronary Stent System. This device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, with s	376 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P110013_S000	Approval for the resolute microtrac zotarolimus-eluting coronary stent system and resolute integrity zotarolimus-eluting coronary stent systems. These devices are indicated for improving coronary lum	431 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P110013_S088	Approval for the Resolute Integrity Zotarolimus-Eluting Coronary Stent System. The device is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus, wi	499 Bytes	2020-03-03	11	-
DevicePMAs@therightstef	P110019_S066	Approval for the expansion of the indications for use of the xience v and xience nano everolimus eluting coronary stent system xience prime and xience prime ll everolimus eluting coronary stent system	1.31 KB	2020-03-03	11	-
DevicePMAs@therightstef	P020026_S000	Approval for the cypher sirolimus-eluting coronary stent on the raptor over-the-wire delivery system or raptorrail rapid exchange delivery system. The device is indicated for improving coronary lumin	481 Bytes	2020-03-03	11	-